Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
18.70
+2.39 (14.62%)
Sep 3, 2025, 3:57 PM - Market open
Beam Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts that cover Beam Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $48.56, which forecasts a 159.75% increase in the stock price over the next year. The lowest target is $21 and the highest is $80.
Price Target: $48.56 (+159.75%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Beam Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $25 → $21 | Hold | Maintains | $25 → $21 | +12.33% | Aug 6, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $78 → $55 | Strong Buy | Maintains | $78 → $55 | +194.20% | May 7, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $75 → $70 | Buy | Maintains | $75 → $70 | +274.43% | May 7, 2025 |
| Barclays | Barclays | Hold Maintains $31 → $25 | Hold | Maintains | $31 → $25 | +33.73% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +327.92% | Apr 7, 2025 |
Financial Forecast
Revenue This Year
46.00M
from 63.52M
Decreased by -27.58%
Revenue Next Year
54.26M
from 46.00M
Increased by 17.95%
EPS This Year
-4.48
from -4.58
EPS Next Year
-4.54
from -4.48
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 86.6M | 115.5M | |||
| Avg | 46.0M | 54.3M | |||
| Low | 6.9M | 29.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 36.4% | 151.1% | |||
| Avg | -27.6% | 18.0% | |||
| Low | -89.2% | -36.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.72 | -3.15 | |||
| Avg | -4.48 | -4.54 | |||
| Low | -4.82 | -5.97 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.